Table 2 Anticipated estimates for DR-TB-related incidence, prevalence and mortality changes over time in the baseline (no-bedaquiline scenario)
| Year | DR-TB epidemiological parameter (all figures in thousands) | ||
|---|---|---|---|
| Incidence | Prevalence | Mortality | |
| 2020 | 69.9 | 218.9 | 30.6 |
| 2030 | 80.7 | 240.0 | 34.9 |
| 2040 | 91.0 | 260.7 | 38.6 |
